PURPOSE: Stereotactic body radiation therapy (SBRT) is an effective treatment for medically
inoperable Stage I non–small-cell lung cancer. However, changes in the patient's breathing …

Stereotactic body radiotherapy is an emerging treatment option for peripheral non-small cell
lung cancer in medically inoperable patients. With high dose per fraction radiotherapy, late …

Objectives Stereotactic ablative radiotherapy (SABR) is a well-established treatment for
medically inoperable peripheral stage I nonsmall cell lung cancer (NSCLC). Previous …

Patients treated with curative-intent lung radiotherapy are in the group at highest risk of severe
complications and death from COVID-19. There is therefore an urgent need to reduce the …

PURPOSE: We studied the outcomes in patients with node positive penile cancer who
received radiotherapy to inguinal and pelvic nodes. Although half of node positive cases are …

Purpose of review The majority of patients with non-small cell lung cancer (NSCLC) present
with advanced disease and overall survival rates are poor. This article outlines the current …

Background Screening with low-dose computed tomography (LDCT) reduces lung cancer
mortality; however, the most effective strategy for optimising participation is unknown. Here we …

Lung cancer is the leading cause of cancer mortality worldwide and most patients are unsuitable
for ‘gold standard’ treatment, which is concurrent chemoradiotherapy. CONCORDE is a …

Background Therapeutic advances have reduced cardiovascular death rates in people with
cardiovascular diseases (CVD). We aimed to define the rates of cardiovascular and …

This study evaluates the dosimetric impact of 4-dimensional computed tomography (4DCT)
target volumes and heterogeneity correction (HC) on target coverage, organ-at-risk (OAR) …